These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25291978)

  • 21. Specificity Studies of the Venezuelan Equine Encephalitis Virus Non-Structural Protein 2 Protease Using Recombinant Fluorescent Substrates.
    Bozóki B; Mótyán JA; Hoffka G; Waugh DS; Tőzsér J
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of Venezuelan equine encephalitis virus with its receptor LDLRAD3.
    Ma B; Huang C; Ma J; Xiang Y; Zhang X
    Nature; 2021 Oct; 598(7882):677-681. PubMed ID: 34646021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of microRNAs induced by Venezuelan equine encephalitis virus infection in mouse brain.
    Bhomia M; Balakathiresan N; Sharma A; Gupta P; Biswas R; Maheshwari R
    Biochem Biophys Res Commun; 2010 Apr; 395(1):11-6. PubMed ID: 20303929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48 h after airborne challenge.
    O'Brien LM; Goodchild SA; Phillpotts RJ; Perkins SD
    Virology; 2012 May; 426(2):100-5. PubMed ID: 22341308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venezuelan equine encephalitis virus non-structural protein 3 (nsP3) interacts with RNA helicases DDX1 and DDX3 in infected cells.
    Amaya M; Brooks-Faulconer T; Lark T; Keck F; Bailey C; Raman V; Narayanan A
    Antiviral Res; 2016 Jul; 131():49-60. PubMed ID: 27105836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
    Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
    Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a cell-based ELISA as a screening tool identifying anti-alphavirus small-molecule inhibitors.
    Spurgers KB; Hurt CR; Cohen JW; Eccelston LT; Lind CM; Lingappa VR; Glass PJ
    J Virol Methods; 2013 Oct; 193(1):226-31. PubMed ID: 23764417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
    Phillpotts RJ; Lescott TL; Jacobs SC
    Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ubiquitin proteasome system plays a role in venezuelan equine encephalitis virus infection.
    Amaya M; Keck F; Lindquist M; Voss K; Scavone L; Kehn-Hall K; Roberts B; Bailey C; Schmaljohn C; Narayanan A
    PLoS One; 2015; 10(4):e0124792. PubMed ID: 25927990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.
    Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS
    Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (1)H, (15)N, (13)C resonance assignment of human osteopontin.
    Platzer G; Żerko S; Saxena S; Koźmiński W; Konrat R
    Biomol NMR Assign; 2015 Oct; 9(2):289-92. PubMed ID: 25616494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of murine B-cell epitopes on Eastern equine encephalitis virus glycoprotein E2.
    EnCheng S; Jing Z; Tao Y; QingYuan X; Yongli Q; WenShi W; Peng W; Liang S; Jing S; DongLai W
    Appl Microbiol Biotechnol; 2013 Jul; 97(14):6359-72. PubMed ID: 23512478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
    Rosas CT; Paessler S; Ni H; Osterrieder N
    Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode.
    Chien CY; Xu Y; Xiao R; Aramini JM; Sahasrabudhe PV; Krug RM; Montelione GT
    Biochemistry; 2004 Feb; 43(7):1950-62. PubMed ID: 14967035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-inhibited State of Venezuelan Equine Encephalitis Virus (VEEV) nsP2 Cysteine Protease: A Crystallographic and Molecular Dynamics Analysis.
    Hoffka G; Lountos GT; Needle D; Wlodawer A; Waugh DS; Tőzsér J; Mótyán JA
    J Mol Biol; 2023 Mar; 435(6):168012. PubMed ID: 36792007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ¹H, ¹⁵N, ¹³C assignment and secondary structure determination of two domains of La protein from D. discoideum.
    Apostolidi M; Vourtsis DJ; Chasapis CT; Stathopoulos C; Bentrop D; Spyroulias GA
    Biomol NMR Assign; 2014 Apr; 8(1):47-51. PubMed ID: 23239108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venezuelan equine encephalitis.
    Weaver SC; Ferro C; Barrera R; Boshell J; Navarro JC
    Annu Rev Entomol; 2004; 49():141-74. PubMed ID: 14651460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Backbone and side-chain (1)H, (15)N, (13)C assignment and secondary structure of BPSL1445 from Burkholderia pseudomallei.
    Quilici G; Berardi A; Gaudesi D; Gourlay LJ; Bolognesi M; Musco G
    Biomol NMR Assign; 2015 Oct; 9(2):347-50. PubMed ID: 25893672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination.
    Perkins SD; O'Brien LM; Phillpotts RJ
    Vaccine; 2006 Apr; 24(17):3440-5. PubMed ID: 16527377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (1)H, (13)C and (15)N resonance assignment of the anti-HIV lectin from Oscillatoria agardhii.
    Carneiro MG; Koharudin LM; Griesinger C; Gronenborn AM; Lee D
    Biomol NMR Assign; 2015 Oct; 9(2):317-9. PubMed ID: 25680849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.